AN2 Therapeutics, Inc. (ANTX)
NASDAQ·Healthcare·Biotechnology
$4.90
+2.94%
Mkt Cap $131.53M
Analyst Ratings
No recent rating data.
Price Target (8 analysts)
$9.00
Range $9.00 – $9.00
Implied Upside
+83.7%
Consensus $9.00 vs current $4.90
NASDAQ·Healthcare·Biotechnology
$4.90
+2.94%
Mkt Cap $131.53M
No recent rating data.
Price Target (8 analysts)
$9.00
Range $9.00 – $9.00
+83.7%
Consensus $9.00 vs current $4.90